Skip to main content

Advertisement

Log in

Treatment of cavernous malformations in supratentorial eloquent areas: experience after 10 years of patient-tailored surgical protocol

  • Original Article - Neurosurgery general
  • Published:
Acta Neurochirurgica Aims and scope Submit manuscript

Abstract

Background

Eloquent area surgery has become safer with the development of intraoperative neurophysiological monitoring and brain mapping techniques. However, the usefulness of intraoperative electric brain stimulation techniques applied to the management and surgical treatment of cavernous malformations in supratentorial eloquent areas is still not proven. With this study, we aim to describe our experience with the use of a tailored functional approach to treat cavernous malformations in supratentorial eloquent areas.

Methods

Twenty patients harboring cavernous malformations located in supratentorial eloquent areas were surgically treated. Individualized functional approach, using intraoperative brain mapping and/or neurophysiological monitoring, was utilized in each case. Eleven patients underwent surgery under awake conditions; meanwhile, nine patients underwent asleep surgery.

Results

Total resection was achieved in 19 cases (95%). In one patient, the resection was not possible due to high motor functional parenchyma surrounding the lesion tested by direct cortical stimulation. Ten (50%) patients presented transient neurological worsening. All of them achieved total neurological recovery within the first year of follow-up. Among the patients who presented seizures, 85% achieved seizure-free status during follow-up. No major complications occurred.

Conclusions

Intraoperative electric brain stimulation techniques applied by a trained multidisciplinary team provide a valuable aid for the treatment of certain cavernous malformations. Our results suggest that tailored functional approach could help surgeons in adapting surgical strategies to prevent patients’ permanent neurological damage.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Fig. 1
Fig. 2
Fig. 3
Fig. 4
Fig. 5
Fig. 6

Similar content being viewed by others

Abbreviations

EBS:

Electric brain stimulation

CM:

Cavernous malformation

DTI:

Diffusion tensor imaging

fMRI:

Functional magnetic resonance imaging

IONM:

Intraoperative neurophysiological monitoring

MRI:

Magnetic resonance imaging

References

  1. Aiba T, Tanaka R, Koike T, Kameyama S, Takeda N, Komata T (1995) Natural history of intracranial cavernous malformations. J Neurosurg 83(1):56–59

    Article  PubMed  CAS  Google Scholar 

  2. Akers A, Al-Shahi Salman R, Awad AI et al (2017) Synopsis of guidelines for the clinical management of cerebral cavernous malformations: consensus recommendations based on systematic literature review by the angioma alliance scientific advisory board clinical experts panel. Neurosurgery 80(5):665–680

    Article  PubMed  PubMed Central  Google Scholar 

  3. Batay F, Bademci G, Deda H (2007) Critically located cavernous malformations. Minim Invasive Neurosurg 50(2):71–76

    Article  PubMed  CAS  Google Scholar 

  4. Berger MS (1995) Functional mapping-guided resection of low-grade gliomas. Clin Neurosurg 42:437–452

    PubMed  CAS  Google Scholar 

  5. Boetto J, Bertram L, Moulinié G, Herbet G, Moritz-Gasser S, Duffau H (2015) Low rate of intraoperative seizures during awake craniotomy in a prospective cohort with 374 supratentorial brain lesions: electrocorticography is not mandatory. World Neurosurg 84(6):1838–1844

    Article  PubMed  Google Scholar 

  6. Chang EF, Gabriel RA, Potts MB, Berger MS, Lawton MT (2011) Supratentorial cavernous malformations in eloquent and deep locations: surgical approaches and outcomes. Clinical article. J Neurosurg 114(3):814–827

    Article  PubMed  Google Scholar 

  7. D'Angelo VA, De Bonis C, Amoroso R et al (2006) Supratentorial cerebral cavernous malformations: clinical, surgical, and genetic involvement. Neurosurg Focus 21(1):e9

    Article  PubMed  Google Scholar 

  8. Daglioglu E, Ergungor F, Polat E, Nacar O (2010) Microsurgical resection of supratentorial cerebral cavernomas. Turk Neurosurg 20(3):348–352

    PubMed  Google Scholar 

  9. Davies JM, Kim H, Lawton MT (2015) Surgical treatment of cerebral cavernous malformations. J Neurosurg Sci 59(3):255–270

    PubMed  CAS  Google Scholar 

  10. De Witt Hamer PC, Robles SG, Zwinderman AH, Duffau H, Berger MS (2012) Impact of intraoperative stimulation brain mapping on glioma surgery outcome: a meta-analysis. J Clin Oncol 30(20):2559–2565

    Article  PubMed  Google Scholar 

  11. Duffau H (2000) Intraoperative direct subcortical stimulation for identification of the internal capsule, combined with an image-guided stereotactic system during surgery for basal ganglia lesions. Surg Neurol 53(3):250–254

    Article  PubMed  CAS  Google Scholar 

  12. Duffau H, Fontaine D (2004) Successful resection of a left insular cavernous angioma using neuronavigation and intraoperative language mapping. Acta Neurochir 147(2):205–208

    Article  PubMed  Google Scholar 

  13. Duffau H, Capelle L, Sichez J et al (1999) Intra-operative direct electrical stimulations of the central nervous system: the Salpêtrière experience with 60 patients. Acta Neurochir 141(11):1157–1167

    Article  PubMed  CAS  Google Scholar 

  14. Duffau H, Capelle L, Denvil D et al (2003) Usefulness of intraoperative electrical subcortical mapping during surgery for low-grade gliomas located within eloquent brain regions: functional results in a consecutive series of 103 patients. J Neurosurg 98(4):764–778

    Article  PubMed  Google Scholar 

  15. Englot DJ, Han SJ, Lawton MT, Chang EF (2011) Predictors of seizure freedom in the surgical treatment of supratentorial cavernous malformations. J Neurosurg 115(6):1169–1174

    Article  PubMed  Google Scholar 

  16. Esposito V, Paolini S, Morace R (2006) Resection of a left insular cavernoma aided by a simple navigational tool. Technical note. Neurosurg Focus 21(1):e16

    Article  PubMed  Google Scholar 

  17. Flemming KD, Link MJ, Christianson TJH, Brown RD (2012) Prospective hemorrhage risk of intracerebral cavernous malformations. Neurology 78(9):632–636

    Article  PubMed  CAS  Google Scholar 

  18. Gabarros A, Young WL, McDermott MW, Lawton MT (2011) Language and motor mapping during resection of brain arteriovenous malformations: indications, feasibility, and utility. Neurosurgery 68(3):744–752

    Article  PubMed  Google Scholar 

  19. Giussani C, Roux F-E, Ojemann J, Sganzerla EP, Pirillo D, Papagno C (2010) Is preoperative functional magnetic resonance imaging reliable for language areas mapping in brain tumor surgery? Review of language functional magnetic resonance imaging and direct cortical stimulation correlation studies. Neurosurgery 66(1):113–120

    Article  PubMed  Google Scholar 

  20. Gralla J, Ganslandt O, Kober H, Buchfelder M, Fahlbusch R, Nimsky C (2003) Image-guided removal of supratentorial cavernomas in critical brain areas: application of neuronavigation and intraoperative magnetic resonance imaging. Minim Invasive Neurosurg 46(2):72–77

    Article  PubMed  CAS  Google Scholar 

  21. Grant GA, Farrell D, Silbergeld DL (2002) Continuous somatosensory evoked potential monitoring during brain tumor resection. Report of four cases and review of the literature. J Neurosurg 97(3):709–713

    Article  PubMed  Google Scholar 

  22. Leal PRL, Houtteville JP, Etard O, Emery E (2010) Surgical strategy for insular cavernomas. Acta Neurochir 152(10):1653–1659

    Article  PubMed  Google Scholar 

  23. Matsuda R, Coello AF, De Benedictis A, Martinoni M, Duffau H (2012) Awake mapping for resection of cavernous angioma and surrounding gliosis in the left dominant hemisphere: surgical technique and functional results: clinical article. J Neurosurg 117(6):1076–1081

    Article  PubMed  Google Scholar 

  24. Nabavi A, Black PM, Gering DT et al (2001) Serial intraoperative magnetic resonance imaging of brain shift. Neurosurgery 48(4):787–797 discussion 797–8

    PubMed  CAS  Google Scholar 

  25. Paolini S, Morace R, Di Gennaro G, Picardi A, Grammaldo LG, Meldolesi GN, Quarato PP, Raco A, Esposito V (2006) Drug-resistant temporal lobe epilepsy due to cavernous malformations. Neurosurg Focus 21(1):e8

    Article  PubMed  Google Scholar 

  26. Poorthuis MHF, Klijn CJM, Algra A, Rinkel GJE, Al-Shahi Salman R (2014) Treatment of cerebral cavernous malformations: a systematic review and meta-regression analysis. J Neurol Neurosurg Psychiatry 85(12):1319–1323

    Article  PubMed  Google Scholar 

  27. Reinges MHT, Nguyen H-H, Krings T, Hütter B-O, Rohde V, Gilsbach JM (2004) Course of brain shift during microsurgical resection of supratentorial cerebral lesions: limits of conventional neuronavigation. Acta Neurochir 146(4):369–377 discussion 377

    Article  PubMed  CAS  Google Scholar 

  28. Sakurada K, Sato S, Sonoda Y, Kokubo Y, Saito S, Kayama T (2006) Surgical resection of tumors located in subcortex of language area. Acta Neurochir 149(2):123–130

    Article  PubMed  Google Scholar 

  29. Sanmillan JL, Fernández-Coello A, Fernández-Conejero I, Plans G, Gabarros A (2016) Functional approach using intraoperative brain mapping and neurophysiological monitoring for the surgical treatment of brain metastases in the central region. J Neurosurg 126(3):698–707

    Article  PubMed  Google Scholar 

  30. Sills AK (2005) Current treatment approaches to surgery for brain metastases. Neurosurgery 57(5 Suppl):S24–S32 discusssion S1–4

    PubMed  Google Scholar 

  31. Ulkatan S, Jaramillo AM, Téllez MJ, Kim J, Deletis V, Seidel K (2016) Incidence of intraoperative seizures during motor evoked potential monitoring in a large cohort of patients undergoing different surgical procedures. J Neurosurg 126(4):1296–1302

    Article  PubMed  Google Scholar 

  32. Wostrack M, Shiban E, Harmening K, Obermueller T, Ringel F, Ryang Y-M, Meyer B, Stoffel M (2012) Surgical treatment of symptomatic cerebral cavernous malformations in eloquent brain regions. Acta Neurochir 154(8):1419–1430

    Article  PubMed  Google Scholar 

  33. Zhou H, Miller D, Schulte DM, Benes L, Rosenow F, Bertalanffy H, Sure U (2009) Transsulcal approach supported by navigation-guided neurophysiological monitoring for resection of paracentral cavernomas. Clin Neurol Neurosurg 111(1):69–78

    Article  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Jose L. Sanmillan.

Ethics declarations

Conflict of interest

All authors certify that they have no affiliations with or involvement in any organization or entity with any financial interest (such as honoraria; educational grants; participation in speakers’ bureaus; membership, employment, consultancies, stock ownership, or other equity interest; and expert testimony or patent-licensing arrangements), or non-financial interest (such as personal or professional relationships, affiliations, knowledge, or beliefs) in the subject matter or materials discussed in this manuscript.

Ethical approval

All procedures performed in studies involving human participants were in accordance with the ethical standards of the institutional and/or national research committee and with the 1964 Helsinki declaration and its later amendments or comparable ethical standards.

Informed consent

For this type of study, formal consent is not required.

Additional information

Comments

The authors present their 10-year surgical experience on cavernous malformation resection with an individualized functional approach using preoperative functional study (fMR and DTI tractography) and intra-operative brain mapping and/or neurophysiological monitoring with awake (11 patients) or asleep (9 patients) surgery. We must congratulate with JL Sanmillan and co-workers because of their remarkable results since they achieved a high resection rate and high seizure control with a low morbidity rate on selected patient population affected by a cavernoma located in an eloquent area.

The issue is remarkable because surgical treatment of cavernous malformations (CMs) in eloquent areas is challenging, and there is an interesting debate in the scientific community about two specific issues when dealing with this subgroup of cavernomas: What should be the indication-to-treat policy and how surgery should be performed when treatment has been planned. For this reason, new data on treatment results and on new approaches are welcome.

We are pleased to get to the heart of the matter with some considerations. First, we agree with the authors about the indication-to-treat policy based on cavernoma features (growing at follow-up, cause of symptoms, or drug-resistant epilepsy) rather than on cavernoma location. However, we must highlight that this policy was possible to the authors because they adopted a functional approach that allowed them to have a low morbidity although operating into crucial areas. Second, we agree with the authors that an intra-operative functional approach is unavoidable when dealing with cavernoma located into or close to an eloquent area; frankly, we think that sometimes preoperative functional imaging can be misleading. As a matter of fact, the authors showed that in 20% of reported cases, surgical strategy had to be changed based on intra-operative brain stimulation findings. To this purpose, we would like to emphasize that brain mapping in cavernoma surgery is crucial not only for the well-known brain shift during surgery but also especially because of unreliability of DTI data in strict proximity of cavernoma to track functional pathway due to artifacts related to hemosiderin surrounding cavernoma. This must be carefully kept in mind when resection of hemosiderin ring around cavernoma is planned. Third, we completely agree with the authors that hemorragic cavernoma in eloquent areas should be removed as soon as possible. We have recently managed the case of a patient affected by an hemorragic cavernoma located close to Broca area presenting with a slight speech disturbance which we planned to postpone surgery to operate on her later, in awake surgery, as far as her language would have recovered. One month after, first bleeding patient presented a second bleeding. She underwent emergent resection in asleep surgery. Fortunately, she finally did not report permanent language disturbances.

We would like to report some further technical considerations arising from our surgical experience on supratentorial cavernoma:

Our policy is to always remove hemosiderin ring surrounding cavernoma, even in non-epileptic patients, when functionally possible. This approach frequently implies perilesional tissue resection larger than expected; thus, we think that neurophysiological monitoring is mandatory even when cavernoma is more distant than 1 cm from a functional area/pathway

In approaching cavernoma located into the parietal areas, we experienced awake surgery not only aiming at language but also at calculation (one case) and at visuo-spatial (one case) intra-operative assessment. Neglect and acalculia remain an underestimated cause of reduced quality of life in patients undergoing surgery in parietal areas. In both patients, explored function was preserved by a surgical injury.

We suggest to charge into the neuronavigation system two MR sequences: one with the aim to track cavernoma (usually T1-weighted images) and the other with the aim to track hemosiderin ring (usually T2 or SWI-weighted images). Although SWI can be limited by the so-called blooming artefact, we experienced a high utility in planning corticotomy based on SWI images charged into neuronavigation system.

Hemosiderin ring can be removed by using CUSA that can allow gentle removal of perilesional healthy tissue, while motor/language pathway can be traced by exploiting the stimulation effect carried out by the ultrasonic device. This approach is well known and widely used in glioma surgery.

An emerging intra-operative tool in CM surgery is ICG-videoangiography. In our experience, it was useful to identify venous malformation, often associated to and in intimate relation with cavernoma.

Some considerations about future perspective in this field of neurosurgery:

1. It would be interesting to test resting state MR (rsMR) application in patients affected by a cavernoma located in an eloquent area when function at risk is not sufficiently assessable at preoperative and intra-operative evaluation.

2. Brain plasticity in cavernoma patients has been not deeply investigated. As the authors interestingly reported in the case with incomplete CM resection, this approach could potentially allow a safer late repeated surgery.

Domenico d’Avella

Alessandro Della Puppa

Padova, Italy

This article is part of the Topical Collection on Neurosurgery General

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Sanmillan, J.L., Lopez-Ojeda, P., Fernández-Conejero, I. et al. Treatment of cavernous malformations in supratentorial eloquent areas: experience after 10 years of patient-tailored surgical protocol. Acta Neurochir 160, 1963–1974 (2018). https://doi.org/10.1007/s00701-018-3644-3

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s00701-018-3644-3

Keywords

Navigation